EP1315507A4 - Hpv-specific short-mers - Google Patents

Hpv-specific short-mers

Info

Publication number
EP1315507A4
EP1315507A4 EP01931140A EP01931140A EP1315507A4 EP 1315507 A4 EP1315507 A4 EP 1315507A4 EP 01931140 A EP01931140 A EP 01931140A EP 01931140 A EP01931140 A EP 01931140A EP 1315507 A4 EP1315507 A4 EP 1315507A4
Authority
EP
European Patent Office
Prior art keywords
mers
hpv
specific short
short
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01931140A
Other languages
German (de)
French (fr)
Other versions
EP1315507A2 (en
Inventor
Radhakrishnan Iyer
Yi Jin
Wenqiang Zhou
Arlene Roland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biowest Therapeutics Inc
Original Assignee
Micrologix Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micrologix Biotech Inc filed Critical Micrologix Biotech Inc
Publication of EP1315507A2 publication Critical patent/EP1315507A2/en
Publication of EP1315507A4 publication Critical patent/EP1315507A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01931140A 2000-04-11 2001-04-11 Hpv-specific short-mers Withdrawn EP1315507A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19599600P 2000-04-11 2000-04-11
US195996P 2000-04-11
PCT/US2001/040501 WO2001077294A2 (en) 2000-04-11 2001-04-11 Hpv-specific short-mers

Publications (2)

Publication Number Publication Date
EP1315507A2 EP1315507A2 (en) 2003-06-04
EP1315507A4 true EP1315507A4 (en) 2004-06-16

Family

ID=22723690

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01931140A Withdrawn EP1315507A4 (en) 2000-04-11 2001-04-11 Hpv-specific short-mers

Country Status (5)

Country Link
EP (1) EP1315507A4 (en)
JP (1) JP2004501614A (en)
AU (1) AU2001257604A1 (en)
CA (1) CA2406485A1 (en)
WO (1) WO2001077294A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632938B2 (en) * 2001-06-07 2003-10-14 Isis Pharmaceuticals, Inc. Processes of purifying oligonucleotides
CA2799586C (en) * 2010-05-19 2018-04-10 Icosagen Cell Factory Oue Method and kit for identifying compounds capable of inhibiting human papilloma virus replication

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039501A2 (en) * 1995-06-06 1996-12-12 Hybridon Inc. Oligonucleotides specific for human papillomavirus
US5681944A (en) * 1989-12-04 1997-10-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides directed to papillomavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863717A (en) * 1989-11-03 1999-01-26 Abbott Laboratories Use of conserved oligonucleotide primers to amplify human papillomavirus DNA sequences
WO1995004748A1 (en) * 1993-08-09 1995-02-16 Isis Pharmaceuticals, Inc. Oligomers for modulating viral processes
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681944A (en) * 1989-12-04 1997-10-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides directed to papillomavirus
WO1996039501A2 (en) * 1995-06-06 1996-12-12 Hybridon Inc. Oligonucleotides specific for human papillomavirus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IYER R P ET AL: "ANTI-PAPILLOMA VIRUS OLIGONUCLEOTIDE", DRUGS OF THE FUTURE, BARCELONA, ES, vol. 27, no. 6, June 2002 (2002-06-01), pages 546 - 557, XP009013793, ISSN: 0377-8282 *
LEWIS E JONATHAN ET AL: "Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus", ANTIVIRAL RESEARCH, vol. 48, no. 3, December 2000 (2000-12-01), pages 187 - 196, XP002276787, ISSN: 0166-3542 *

Also Published As

Publication number Publication date
WO2001077294A2 (en) 2001-10-18
AU2001257604A1 (en) 2001-10-23
JP2004501614A (en) 2004-01-22
EP1315507A2 (en) 2003-06-04
WO2001077294A3 (en) 2002-04-04
CA2406485A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DE60105852D1 (en) Fluidmischsystem
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60115644D1 (en) Thiazinoxazolidinon
AU3391801A (en) Pyridinylimidazoles
AU8274301A (en) Electro-powder
DE50104081D1 (en) Hydrolager
DE50105205D1 (en) Creatinin-biosensor
DE60114954D1 (en) Polytrimethylenterephthalatgarn
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE50112014D1 (en) Stiftheizer
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50107703D1 (en) Creatininsensor-kalibration
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE60114837D1 (en) Signalmessung
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114303D1 (en) Nsaugluftkanal
DE50114375D1 (en) Compound-reibungsvakuumpumpe
AU4686401A (en) Hypotensors
AU9187601A (en) Triazolo-epothilones
DE50100877D1 (en) Thermoverformbares verbundmaterial

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021111

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MICROLOGIX BIOTECH, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 31/20 B

Ipc: 7A 61K 31/7125 B

Ipc: 7A 61K 31/711 B

Ipc: 7A 61K 31/7105 B

Ipc: 7C 12N 15/11 B

Ipc: 7C 07H 21/04 B

Ipc: 7C 07H 21/02 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040429

17Q First examination report despatched

Effective date: 20041025

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050505

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1056833

Country of ref document: HK